Questions? Call 800-624-6242
|
|
|
|
|
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Page 208
Bibliography
Abbott JD, Preston NW, Mackay RI. 1971. Agglutinin response to
pertussis vaccination in the child. British Medical Journal
1:86-89.
Ada GL. 1990. The immunological principles of vaccination.
Lancet 335:523-526.
Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B,
Kyselova M, Demelova M, Hejdova E. 1969. Comparative study of the
reactogenicity and efficacy of different combined vaccines against
diphtheria, pertussis and tetanus. Progress in Immunobiological
Standardization 3:290-291.
Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B,
Kyselova M, Demelova M, Hejdova E. 1970. Comparative study of the
reactogenicity and effectiveness of different combined vaccines
against diphtheria, pertussis and tetanus. Journal of Hygiene,
Epidemiology, Microbiology and Immunology 14:88-101.
Ad Hoc Group for the Study of Pertussis Vaccines. 1988.
Placebo-controlled trial of two acellular pertussis vaccines in
Sweden: protective efficacy and adverse events. Lancet
1:955-960.
Adler SP. 1982. The effects and side effects of vaccines.
Virginia Medical Journal 109:410-411.
Aicardi J. 1989. Status epilepticus. Pediatrics 84:939-940.
Aicardi J, Chevrie JJ. 1975. Accidents neurologiques consecutifs
a la vaccination contre la coqueluche. [Neurological complications
following immunization against pertussis.] Archives Francaises de
Pediatrie 32:309-317.
Alderslade R, Bellman MH, Rawson NSB, Ross EM, Miller DL. 1981.
The National Childhood Encephalopathy Study: a report on 1000 cases
of serious neurological disorders in infants and young children
from the NCES research team. In: Whooping Cough: Reports from the
Committee on the Safety of Medicines and the Joint
|
|
|
|
|
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 208
Page 208
Bibliography
Abbott JD, Preston NW, Mackay RI. 1971. Agglutinin response to
pertussis vaccination in the child. British Medical Journal
1:86-89.
Ada GL. 1990. The immunological principles of vaccination.
Lancet 335:523-526.
Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B,
Kyselova M, Demelova M, Hejdova E. 1969. Comparative study of the
reactogenicity and efficacy of different combined vaccines against
diphtheria, pertussis and tetanus. Progress in Immunobiological
Standardization 3:290-291.
Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B,
Kyselova M, Demelova M, Hejdova E. 1970. Comparative study of the
reactogenicity and effectiveness of different combined vaccines
against diphtheria, pertussis and tetanus. Journal of Hygiene,
Epidemiology, Microbiology and Immunology 14:88-101.
Ad Hoc Group for the Study of Pertussis Vaccines. 1988.
Placebo-controlled trial of two acellular pertussis vaccines in
Sweden: protective efficacy and adverse events. Lancet
1:955-960.
Adler SP. 1982. The effects and side effects of vaccines.
Virginia Medical Journal 109:410-411.
Aicardi J. 1989. Status epilepticus. Pediatrics 84:939-940.
Aicardi J, Chevrie JJ. 1975. Accidents neurologiques consecutifs
a la vaccination contre la coqueluche. [Neurological complications
following immunization against pertussis.] Archives Francaises de
Pediatrie 32:309-317.
Alderslade R, Bellman MH, Rawson NSB, Ross EM, Miller DL. 1981.
The National Childhood Encephalopathy Study: a report on 1000 cases
of serious neurological disorders in infants and young children
from the NCES research team. In: Whooping Cough: Reports from the
Committee on the Safety of Medicines and the Joint
OCR for page 209
Page 209
Committee on Vaccination and Immunisation. Department of Health
and Social Security. London: Her Majesty's Stationery Office.
Alford CA, Griffiths PD. 1983. Rubella. In: Remington JS, Klein
JE, eds. Infectious Diseases of the Fetus and Newborn Infant.
Philadelphia: W.B. Saunders Co.
Alford CA, Neva, FA, Weller TH. 1964. Virologic and serologic
studies on human products of conception after maternal rubella. New
England Journal of Medicine 271:1275-1281.
Alfrey AC. 1984. Aluminium intoxication. New England Journal of
Medicine 310:1113-1115.
Alfrey AC, LeGendre GR, Kaehny WD. 1976. The dialysis
encephalopathy syndrome. New England Journal of Medicine
294:184-188.
Alicata P, Castro A, Faro S, Motta S. 1988. Lymphocytes
proliferation kinetics and SCE variation after rubella vaccination.
Mutation Research 198:215-219.
Allen AD. 1988. Is RA27/3 rubella immunization a cause of
chronic fatigue? Medical Hypotheses 27:217-220.
Al-Qudah AA, Shahar E, Logan WJ, Murphy EG. 1988. Neonatal
Guillain-Barrè syndrome. Pediatric Neurology 4:255-256.
Altmann P, Hamon C, Blair J, Dhanesha U, Cunningham J, Marsh F.
1989. Disturbance of cerebral function by aluminium in
haemodialysis patients without overt aluminium toxicity. Lancet
2:7-11.
Ambrosch F, Wiedermann G. 1979. Changes of risk and benefit in
immunization against pertussis and tuberculosis. In: International
Symposium on Immunization, Brussels, 1978. Developments in
Biological Standardization 43:85-90.
American Academy of Pediatrics. 1944. Report of the Committee on
Infectious Diseases: Pertussis. Evanston, IL: American Academy of
Pediatrics.
American Academy of Pediatrics. 1980. Consensus statement.
Febrile seizures: long-term management of children with
fever-associated seizures. Pediatrics 66:1009-1012.
American Academy of Pediatrics, Committee on Infectious
Diseases. 1982. Red Book update. Pediatrics 70:819-820.
American Academy of Pediatrics. 1986. The Red Book. Report of
the Committee on Infectious Diseases, 20th edition. Peter G, ed.
Elk Grove, IL: American Academy of Pediatrics.
American Academy of Pediatrics, Committee on Infectious
Diseases. 1987. Family history of convulsions in candidates for
immunization with pertussis-containing vaccines (diphtheria,
tetanus, pertussis). Pediatrics 80:743-744.
American Academy of Pediatrics. 1988. The Red Book. Report of
the Committee on Infectious Diseases, 21st edition. Peter G, ed.
Elk Grove, IL: American Academy of Pediatrics.
American Academy of Pediatrics. 1990. Infectious disease expert
delivers DTP testimony. AAP News (September):9, 18, 19.
American Academy of Pediatrics. 1991a. The status of acellular
pertussis vaccines: current perspective. AAP News (May):14-15,
23.
American Academy of Pediatrics. 1991b. The relationship between
pertussis vaccine and brain damage: reassessment. AAP News
(May):18-19.
American Journal of Diseases of Children. 1969. International
conference on rubella immunization. 118:1-410.
OCR for page 210
Page 210
American Medical Association. 1984. Report of Ad Hoc Commission
on Vaccines Injury Compensation. Chicago.
American Medical Association, Ad Hoc Panel on Pertussis Vaccine
Injury. 1985. Pertussis vaccine injury. Journal of the American
Medical Association 254:30833085.
American Psychiatric Association. 1968. Diagnostic and
statistical manual of mental disorders, 2nd edition (DSM II).
Washington, DC: American Psychiatric Association.
American Psychiatric Association. 1980. Diagnostic and
statistical manual of mental disorders, 3rd edition (DSM III).
Washington, DC: American Psychiatric Association.
American Psychiatric Association. 1987. Diagnostic and
Statistical Manual of Mental Disorders, 3rd edition, revised (DSM
III-R). Washington, DC: American Psychiatric Association.
Amiel SA. 1976. The effects of Bordetella pertussis
vaccine on cerebral vascular permeability. British Journal of
Experimental Pathology 57:653-662.
Amiel-Tison C. 1973. Neurologic disorders in neonates associated
with abnormalities of pregnancy and birth. Current Problems of
Pediatrics 3:3-37.
Anderson EK. 1953. Serological studies on H. pertussis, H.
parapertussis, and H. bronchisepticus. Acta Pathologica
Microbiologica Scandinavica 33:202-224.
Anderson EL, Belshe RB, Bartram J. 1985. Clinical evaluation of
acellular pertussis DT vaccine in young children. Abstract E27.
Presented at the 85th Annual Meeting of the American Society for
Microbiology, Las Vegas.
Anderson EL, Belshe RB, Bartram J, Gurwith M, Hung P, Levner M,
Vernon SK. 1987. Clinical and serologic responses to acellular
pertussis vaccine in infants and young children. American Journal
of Diseases of Children 141:949-953.
Anderson EL, Belshe RB, Bartram J. 1988. Differences in
reactogenicity and antigenicity of acellular and standard pertussis
vaccines combined with diphtheria and tetanus in infants. Journal
of Infectious Diseases 157:731-737.
Anderson GR. 1976. Problems associated with the development and
clinical testing of an improved pertussis vaccine. In: Perlman D,
ed. Advances in Applied Microbiology, Vol. 20. Madison, WI:
Academic Press.
Anderson I, Morris D. 1950. Encephalopathy after combined
diphtheria-pertussis inoculation. Lancet 1:537-539.
Anderson R, May R. 1982. The logic of vaccination. New Scientist
96:410-415.
Angell M. 1990. The interpretation of epidemiologic studies. New
England Journal of Medicine 323:823-825.
Annegers JF, Hauser WA, Shirts SB, Kurland LT. 1987. Factors
prognostic of unprovoked seizures after febrile convulsions. New
England Journal of Medicine 316:493498.
Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. 1988.
The risk of unprovoked seizures after encephalitis and meningitis.
Neurology 38:1407-1410.
Aoyama T, Murase Y, Kato T, Iwata T. 1985. Efficacy of an
acellular pertussis vaccine in Japan. Journal of Pediatrics
107:180-183.
Aoyama T, Hagiwara S, Murase Y, Kato T, Iwata T. 1986. Adverse
reactions and antibody responses to acellular pertussis vaccine.
Journal of Pediatrics 109:925930.
OCR for page 211
Page 211
Aoyama T, Murase Y, Gonda T, Iwata T. 1988. Type-specific
efficacy of acellular pertussis vaccine. American Journal of
Diseases of Children 142:40-42.
Aoyama T, Goto R, Iwai H, Murase Y, Iwata T. 1990. Pertussis in
the adult. In: Manclark CR, ed. Sixth International Symposium on
Pertussis, Abstracts. DHHS Publication No. (FDA) 90-1162. Bethesda,
MD: Public Health Service, U.S. Department of Health and Human
Services.
Arai H, Sato Y. 1976. Separation and characterization of two
distinct hemagglutinins contained in purified
leukocytosis-promoting factor from Bordetella pertussis.
Biochimica Biophysica Acta 444:765-782.
Arima M, Fukuyama Y, Nagahata M, Okada R, Kubota T. 1959. The
prompt reaction and delayed reaction of the central nervous system
following immunization. Nihon Shonika Gakukai Zasshi [Journal of
the Japanese Pediatric Association] 63:1298-1303. [in Japanese]
Armitage P, Perry WLM. 1957. British standard for pertussis
vaccine: its use in routine control of commercial vaccines. British
Medical Journal 2:501-505.
Arora S, Sanyal RK. 1968. The role of the adrenergic system in
the mechanism of action of Bordetella pertussis vaccine.
International Archives of Allergy 33:299305.
Arora S, Sanyal RK, West GB. 1970. The sensitizing action of
Bordetella pertussis vaccine. International Archives of Allergy
37:357-365.
Ash D. 1982. Whooping cough immunization. Medical Journal of
Australia 1:369370.
Ashworth LAE, Irons LI, Dowsett AB. 1982. Antigenic relationship
between serotype-specific agglutinogen and fimbriae of
Bordetella pertussis. Infection and Immunity 37:1278-1281.
Askelof P, Bartfai T. 1979. Effect of whooping-cough vaccine on
cyclic-GMP levels in the brain. FEMS Microbiology Letters
6:223-225.
Assaad F, Ljungars-Esteves L. 1985. Rubella—world impact.
Reviews of Infectious Diseases 7:S29-S36.
Au-Jensen M, Heron I. 1985. Is the acute encephalopathy test in
mice suited for control of pertussis vaccines? Developments in
Biological Standardization 61:447451.
Au-Jensen M, Heron I. 1987. Synergistic teratogenic effect
produced in mice by whole cell pertussis vaccine. Vaccine
5:215-218.
Austin SM, Altman R, Barnes EK, Dougherty WJ. 1972. Joint
reactions in children vaccinated against rubella. I. Comparison of
two vaccines. American Journal of Epidemiology 95:53-58.
Azeemuddin S. 1987. Thrombocytopenia purpura after combined
vaccine against measles, mumps, and rubella. Clinical Pediatrics
26:318.
Badgett JT, Rodgers GC. 1987. Safety and immunogenicity of a
diphtheria-tetanuspertussis vaccine containing an acellular
pertussis component. Southern Medical Journal 80:1075-1078.
Baeva EA, Selezneva TS, Kucherovskaya TV, Auzinya AV, Glinskaya
EV. 1986. Reactogenic properties of adsorbed
diphtheria-pertussis-tetanus vaccine with the reduced content of
antigens. Zhurnal Mikrobiologii Epidemiologii Immunobiologii
10:47-50.
Bailey G. 1962. Carpal-tunnel syndrome (letter). British Medical
Journal 1:1207.
OCR for page 212
Page 212
Baird H, Borofsky LG. 1957. Infantile myoclonic spasm. Journal
of Pediatrics 50:332339.
Baker RH. 1981. Pertussis immunisation and serious acute
neurological illness in children (letter). British Medical Journal
282:1870.
Baldini M. 1966. Idiopathic thrombocytopenic purpura. New
England Journal of Medicine 274:1245-1251.
Balfour HH, Balfour CL, Edelman CK, Rierson PA. 1976. Evaluation
of Wistar RA27/3 rubella virus vaccine in children. American
Journal of Diseases of Children 130:1089-1091.
Balfour HH, Groth KE, Edelman CK. 1980. RA 27/3 rubella vaccine.
American Journal of Diseases of Children 134:350-353.
Banks WA, Kastin AJ. 1989. Aluminum-induced neurotoxicity:
alterations in membrane function at the blood-brain barrier.
Neuroscience & Biobehavioral Reviews 13:47-53.
Bannatyne RM, Cheung R. 1981. Reducing the endotoxic activity of
pertussis vaccine. Journal of Hygiene (Cambridge) 87:377-381.
Baraff LJ, Cherry JD. 1979. Nature and rates of adverse
reactions associated with pertussis immunization. In: Manclark CR,
Hill JD (eds). International Symposium on Pertussis. U.S.
Department of Health, Education, and Welfare Publication No. (NIH)
79-1830. Washington, DC: U.S. Government Printing Office.
Baraff LJ, Cherry JD, Cody CL, Manclark CR. 1980. Pertussis
vaccine project: rates, nature and etiology of adverse reactions
associated with DTP vaccine. Unpublished.
Baraff LJ, Ablon WJ, Weiss RC. 1983. Possible temporal
association between diphtheria-tetanus toxoid-pertussis vaccination
and sudden infant death syndrome. Pediatric Infectious Disease
Journal 2:7-11.
Baraff LJ, Cody CL, Cherry JD. 1984a. DTP-associated reactions:
an analysis by injection site, prior reactions, and dose.
Pediatrics 73:31-36.
Baraff LJ, Leake RD, Burstyn DG, Payne T, Cody CL, Manclark CR,
St. Geme JW. 1984b. Immunologic response to early and routine DTP
immunization in infants. Pediatrics 73:37-42.
Baraff LJ, Cherry JD, Cody CL, Marcy SM, Manclark CR. 1985. DTP
vaccine reactions: effect of prior reactions on rate of subsequent
reactions. Developments in Biological Standardization
61:423-428.
Baraff LJ, Shields D, Beckwith L, Strome G, Marcy SM, Cherry JD,
Manclark CR. 1988. Infants and children with convulsions and
hypotonic-hyporesponsive episodes following
diphtheria-tetanus-pertussis immunization: follow-up evaluation.
Pediatrics 81:789-794.
Baraff LJ, Manclark CR, Cherry JD, Christenson P, Marcy M. 1989.
Analyses of adverse reactions to diphtheria and tetanus toxoids and
pertussis vaccine by vaccine lot, endotoxin content, pertussis
vaccine potency and percentage of mouse weight gain. Pediatric
Infectious Disease Journal 8:502-507.
Barkin RM, Pichicero ME. 1979. Diphtheria-pertussis-tetanus
vaccine: reactogenicity of commercial products. Pediatrics
63:256-260.
Barkin RM, Samuelson JS, Gotlin LP. 1984. DTP reactions and
serologic response with a reduced dose schedule. Journal of
Pediatrics 105:189-194.
Barkin RM, Samuelson JS, Gotlin LP. 1985. Diphtheria and tetanus
toxoids and
OCR for page 213
Page 213
pertussis vaccine adsorbed (DTP): response to varying immunizing
dosage and schedule. Developments in Biological Standardization
61:297-307.
Barnes EK, Altman R, Austin SM, Dougherty WJ. 1972. Joint
reactions in children vaccinated against rubella. Study II:
Comparison of three vaccines. American Journal of Epidemiology
95:59-66.
Barnes JM, Hilton MJ. 1970. The value of the mouse toxicity test
for screening pertussis vaccine. International Symposium on
Pertussis, Bilthoven, 1969. Symposia Series in Immunobiological
Standardization 13:180-184.
Barrie H. 1983. Campaign of terror. American Journal of Diseases
of Children 137:922-923.
Bartley TD, Whiteley DW, Mar VL, Burns DL, Burnette WN. 1989.
Pertussis holotoxoid formed in vitro with a genetically deactivated
S1 subunit. Proceedings of the National Academy of Sciences
86:8353-8357.
Bartos HR. 1972. Thrombocytopenia associated with rubella
vaccination. New York State Journal of Medicine 72:499.
Bass JW. 1985. Pertussis: current status of prevention and
treatment. Pediatric Infectious Diseases 4:614-619.
Bassili WR, Stewart GT. 1976. Epidemiological evaluation of
immunization and other factors in the control of whooping cough.
Lancet 1:471-473.
Battista RN, Lawrence RS, eds. 1988. Implementing Preventive
Services. New York: Oxford University Press. Supplement to American
Journal of Preventive Medicine 4(4).
Baumann E, Binder E, Falk W, Huber EG, Kurz R, Rosanelli K.
1985. Development and clinical use of an oral heat-inactivated
whole cell pertussis vaccine. Developments in Biological
Standardization 61:511-516.
Bayer AS. 1980. Arthritis related to rubella: a complication of
natural rubella and rubella immunization. Postgraduate Medicine
67:131-134.
Bayer WL, Sherman FE, Michaels RH, Szeto ILF, Lewis JH. 1965.
Purpura in congenital and acquired rubella. New England Journal of
Medicine 273:13621366.
Becker RH. Pertussis immunisation and serious acute neurological
illness in children. British Medical Journal 282:1870.
Beckwith JB. 1973. The sudden infant death syndrome. Current
Problems in Pediatrics 3:3-36.
Becus-Laurentiu M, Szabo-Adorjan E, Pozsgi N, Szabo S. 1974.
Etude histochimique de l'ovaire de ratte: l'effet du choc
anaphylactique et du vaccin pertussis. Archives Roumaines de
Pathologie Experimentale et de Microbiologie 33:97-106.
Beghi E, Kurland LT, Mulder DW. 1982. Incidence of acute
transverse myelitis in Rochester, Minnesota, 1970-1980, and
implications with respect to influenza vaccine. Neuroepidemiology
1:176-188.
Beghi E, Nicolosi AN, Kurland LT, Mulder DW, Hauser WA, Shuster
L. 1984. Encephalitis and aseptic meningits, Olmsted County,
Minnesota, 1950-1981. I. Epidemiology. Annals of Neurology
16:283-294.
Beghi E, Kurland LT, Mulder DW, Nicolosi A. 1985. Brachial
plexus neuropathy in the population of Rochester, Minnesota,
1970-1981. Annals of Neurology 18:320323.
OCR for page 214
Page 214
Behan PO. 1977. Diffuse myelitis associated with rubella
vaccination (letter). British Medical Journal 1:166.
Behan PO. 1989. Report on the neurological complications of
pertussis vaccination in children. August 1989. Unpublished.
Behrman RE, Vaughan VC, eds. 1987. Nelson's Textbook of
Pediatrics, 16th edition. Philadelphia: W.B. Saunders Co.
Behrman S. 1981. Pertussis immunisation and serious acute
neurological illness in children (letter). British Medical Journal
282:1871.
Bell of Atri, Inc. 1990. Letter from J. Anthony Morris to Dean
A. Blumberg, October 19, 1990. Submitted to Institute of Medicine
Committee to Review the Adverse Consequences of Pertussis and
Rubella Vaccines. Unpublished.
Bellman MH. 1983. Serious acute neurological diseases of
children: a clinical and epidemiological investigation with special
reference to whooping cough disease and immunization. Unpublished
thesis submitted for the degree of Doctor of Medicine, University
of London.
Bellman MH, Ross EM. 1985. Pertussis immunization and fits. In:
Ross E, Reynolds E, eds. Paediatric Perspectives on Epilepsy. New
York: John Wiley & Sons.
Bellman MH, Ross EM, Miller DL. 1982. Reye's syndrome in
children under three years old. Archives of Disease in Childhood
57:259-263.
Bellman MH, Ross EM, Miller DL. 1983a. Infantile spasms and
pertussis immunisation. Lancet 1:1031-1034.
Bellman MH, Ross EM, Miller DL. 1983b. Pertussis vaccine and
infantile spasms (letter). Lancet 2:278-279.
Bellman MH, Rawson NSB, Wadsworth J, Ross EM, Cameron S, Miller
DL. 1985. A developmental test based on the STYCAR sequences used
in the National Childhood Encephalopathy Study. Child: Care, Health
and Development 11:309-323.
Benacerraf B, Kabat EA. 1950. A quantitative study of the Arthus
phenomenon induced passively in the guinea pig. Journal of
Immunology 64:1-19.
Bender L. 1942. Post encephalitic behavior disorders in
childhood. In: Bender L, ed. Encephalitis: A Clinical Study. New
York: Grune & Stratton.
Berenbaum MC, Ungar J, Stevens WK. 1960. Intracranial infection
of mice with Bordetella pertussis. Journal of General
Microbiology 22:313-322.
Berg JM. 1958. Neurological complications of pertussis
immunization. British Medical Journal 2:24-27.
Berger SA, Ginsberg GM, Slater PE. 1990. Cost-benefit analysis
of routine mumps and rubella vaccination for Israeli infants.
Israel Journal of Medical Science 26:7480.
Bergman RK, Munoz JJ. 1975. Effect of Bordetella
pertussis extract and vasoactive amines on vascular
permeability. Journal of Allergy and Clinical Immunology
55:378-385.
Bergman RK, Munoz JJ, Portis JL. 1978. Vascular permeability
changes in the central nervous system of rats with hyperacute
experimental allergic encephalomyelitis induced with the aid of a
substance from Bordetella pertussis. Infection and Immunity
21:627-637.
Berkow R, ed. 1987. Pertussis. Merck Manual of Diagnosis and
Therapy, 15th edition. Rahway, NJ: Merck Sharpe & Dohme
Research Laboratories.
OCR for page 215
Page 215
Berlin BS. 1983. Convulsions after measles immunization. Lancet
1:1380.
Bernbaum JC, Daft A, Anolik R. 1985. Response of preterm infants
to diphtheriatetanus-pertussis immunizations. Journal of Pediatrics
107:184-188.
Bernier RH. 1982. Prospects for a new pertussis vaccine. In:
Centers for Disease Control. Seventeenth Immunization Conference
Proceedings. Washington, DC: U.S. Government Printing Office.
Bernier RH, Frank JA, Nolan TF. 1981. Abscesses complicating DTP
vaccination. American Journal of Diseases of Children
135:826-828.
Bernier RH, Frank JA, Dondero TJ, Turner P. 1982.
Diphtheria-tetanus toxoidspertussis vaccination and sudden infant
deaths in Tennessee. Journal of Pediatrics 101:419-421.
Berry PS, Cohen RA. 1990. Statement of Phillip S. Berry and
Ralph A. Cohen to Committee to Review the Adverse Consequences of
Pertussis and Rubella Vaccines. Institute of Medicine Public
Meeting on Adverse Consequences of Pertussis and Rubella Vaccines,
Washington, DC, January 10, 1990. Unpublished.
Best JM, Banatvala JE, Bowen JM. 1974. New Japanese rubella
vaccine: comparative trials. British Medical Journal 3:221-224.
Best JM, Banatvala JE, Morgan-Capner P, Miller E. 1989. Fetal
infection after maternal reinfection with rubella: criteria for
defining reinfection. British Medical Journal 299:773-775.
Bishop WB, Carlton RF, Sanders LL. 1966. Diffuse vasculitis and
death after hyperimmunization with pertussis vaccine: report of a
case. New England Journal of Medicine 274:616-619.
Black FL, Lamm SH, Emmons JE, Pinheiro FP. 1976. Reactions to
rubella vaccine and persistence of antibody in virgin-soil
populations after vaccination and wild-virus-induced immunization.
Journal of Infectious Diseases 133:393-398.
Black NA, Kurtz JB, Lacey A, Parsons A, McWhinney N, Mayon-White
RT. 1983. Post-partum rubella immunisations: a controlled trial of
two vaccines. Lancet 2:990-992.
Black WJ, Munoz JJ, Peacock MG, Schad PA, Cowell JL, Burchall
JJ, Lim M, Kent A, Steinman L, Falkow S. 1988.
ADP-ribosyltransferase activity of pertussis toxin and
immunomodulation by B. pertussis. Science 240:656-659.
Blackwelder W, Olin P, Storsaeter J. 1988. Efficacy trial in
Sweden: design and results. Presented at NIAID/FDA/CDC/USAID Status
of Acellular Pertussis Vaccines—Swedish Trial Update,
Bethesda, Maryland, Febuary 8-9, 1988.
Blanc S, Leuenberger P, Berger J-P, Brooke EM, Schelling J-L.
1979. Judgments of trained observers on adverse drug reactions.
Clinical Pharmacology and Therapeutics 25:493-498.
Blattner RJ, Feigin RD. 1986. Diphtheria, pertussis, and tetanus
(DTP) immunization local reactions do not predict central nervous
system reactions. Pediatrics 78:1168-1169.
Bleck TP. 1990. Time course of adverse events following exposure
to known neurotoxic and immunotoxic agents. Presentation for
Committee to Review the Adverse Consequences of Pertussis and
Rubella Vaccines. Institute of Medicine Workshop on Possible
Adverse Consequences of Pertussis and Rubella Vaccines, Washington,
DC, May 14, 1990. Unpublished.
OCR for page 216
Page 216
Blennow M, Granstrom M. 1989a. Adverse reactions and serologic
response to a booster dose of acellular pertussis vaccine in
children immunized with acellular or whole-cell vaccine as infants.
Pediatrics 84:62-67.
Blennow M, Granstrom M. 1989b. Sixteen-month follow-up of
antibodies to pertussis toxin after primary immunization with
acellular or whole cell vaccine. Pediatric Infectious Disease
Journal 8:621-625.
Blennow M, Granstrom M. 1990. Long term serologic follow-up
after pertussis immunization. Pediatric Infectious Disease Journal
9:21-26.
Blennow M, Granstrom M, Jaatmaa E, Olin P. 1988. Primary
immunization of infants with an acellular pertussis vaccine in a
double-blind randomized clinical trial. Pediatrics 82:293-299.
Bloom BR. 1989. Vaccines for the third world. Nature
342:115-120.
Blumberg DA, Morgan CA, Lewis K, Leach C, Holtzman A, Levin SR,
Baraff LJ, Cherry JD. 1988. An ongoing surveillance study of
persistent crying and hypotonic-hyporesponsive episodes following
routine DTP immunization: a preliminary report. Tokai Journal of
Experimental and Clinical Medicine 13(Suppl.):133136.
Blumberg DA, Mink CM, Lewis K, Chatfield P, Leach C, Smith LP,
Christenson PD, Guravita L, Steinfeld MBJ, March SM, Levin SR,
Baraff LJ, Schonfeld N, Cherry JD. In press. Pathophysiology of
reactions associated with pertussis vaccine. Developments in
Biological Standardization.
Blumstein GI, Kreithen H. 1966. Peripheral neuropathy following
tetanus toxoid administration. Journal of the American Medical
Association 198:1030-1031.
Bobele GB, Bodensteiner JB. 1990. Infantile spasms. Neurologic
Clinics 8:633-645.
Bokoch GM, Katada T, Northrup JK, Hewlitt EL, Gilman AG. 1983.
Identification of the predominant substrate for ADP-ribosylation by
islet cell activating protein. Journal of Biochemistry
258:2072-2075.
Bond D. 1985. Former nurse sues vaccine manufacturer.
Spokesman-Review, Spokane, WA, February 7, 1985, p.6.
Bordet J, Gengou O. 1906. Le microbe de la coqueluche. Annales
Institut Pasteur 20:731-741.
Bottiger L, Westerholm B. 1973. Drug-induced blood dyscrasias in
Sweden. British Medical Journal 3:339-343.
Bouvier-Colle MH, Flahaut A, Messiah A, Jougla E, Hatton F.
1989. Sudden infant death and immunization: an extensive
epidemiological approach to the problem in France—winter 1986.
International Journal of Epidemiology 18:121-126.
Bower BD, Jeavons PM. 1960. Complications of immunization.
British Medical Journal 2:1453.
Bowie C. 1990. Lessons from the pertussis vaccine court trial.
Lancet 335:397-399.
Bracken MB. 1989. Potential biases related to date of onset
assignment in the (British) National Childhood Encephalopathy
Study. Institute of Medicine Workshop on the National Childhood
Encephalopathy Study, Washington, DC, November 7-8, 1989.
Unpublished.
Bradford WL, Day E, Martin F. 1949. Humoral antibody formation
in infants aged one to three months injected with a triple
(diphtheria-tetanus-pertussis) alumprecipitated antigen. Pediatrics
4:711-717.
OCR for page 217
Page 217
Braginskaya VP, Sokolova AF, Ozeretskovsky NA. 1980.
Post-vaccination neurological complications in children. Zhurnal
Nevropatologii Psikhiatrii 80:199-203.
Brahams D. 1986. Medicine and the law: does pertussis vaccine
cause brain damage? Lancet 1:1284.
Brahams D. 1988. Pertussis vaccine: court finds no justification
for association with permanent brain damage. Lancet 1:837.
Brahams D. 1990. Medicine and the law: pertussis vaccine
litigation. Lancet 335:905906.
Brauer H. 1988. Are we sweeping DTP contraindications under the
rug? (letter). American Journal of Diseases of Children
142:698.
Brewis M, Poskanzer DC, Rolland C, Miller H. 1966. Neurological
disease in an English city. Acta Neurologica Scandinavica 42(Suppl.
24):9-89.
Brink EW. 1982. Pertussis update. In: Centers for Disease
Control. Seventeenth Immunization Conference Proceedings.
Washington, DC: U.S. Government Printing Office.
British Medical Journal. 1974. Vaccination against whooping
cough (editorial). 3:539-540.
British Medical Journal. 1981. Pertussis vaccine (editorial).
282:1563-1564.
British Medical Journal. 1986. The law tries to decide whether
whooping cough vaccine causes brain damage: Professor Gordon
Stewart gives evidence. 292:12641266.
British Medical Journal. 1990. Wellcome to stop vaccine
production. 301:777.
British National Formulary. 1988. London: British Medical
Association/Pharmaceutical Society of Great Britain.
Brodribb HS. 1963. Rubella (1962) in three boarding schools: its
complications and types. British Journal of Clinical Practice
17:726-730.
Brody JA. 1966. The infectiousness of rubella and the
possibility of reinfection. American Journal of Public Health
56:1082-1087.
Brody M, Sorley RG. 1947. Neurologic complications following the
administration of pertussis vaccine. New York State Journal of
Medicine 47:1016-1017.
Broome CV, Fraser DW. 1981. Pertussis in the United States,
1979: a look at vaccine efficacy. Journal of Infectious Diseases
144:187-190.
Broome CV, Fraser DW, English WJ. 1979. Pertussis: diagnostic
methods and surveillance. In: Manclark CR, Hill JC, eds. 1979.
International Symposium on Pertussis. U.S. Department of Health,
Education, and Welfare Publication No. (NIH) 79-1830. Washington,
DC: U.S. Government Printing Office.
Broome CV, Preblud SR, Bruner B, McGowan JE, Hayes PS, Harris
PR, Elsea W, Fraser DW. 1981. Epidemiology of pertussis, Atlanta,
1977. Journal of Pediatrics 98:362-367.
Brown PE. 1981. Effect of vaccination on severity and
dissemination of whooping cough (letter). British Medical Journal
283:60.
Brunell P. 1983. Impact of litigation on immunization of
children. Pediatrics 72:822823.
Bryan H. 1988. Home monitoring in infants at risk for SIDS. In:
Harper RM, Hoffman HJ, eds. Sudden Infant Death Syndrome Risk
Factors and Basic Mechanisms. New York: PMA Publishing Corp.
Bryceson ADM. 1976. Clinical pathology of the Jarisch-Herxheimer
reaction. Journal of Infectious Diseases 133:696-704.
OCR for page 218
Page 218
Buchanan D. 1946. Convulsions in infancy and childhood. Medical
Clinics of North America 30:163-171.
Bui-Authier F, Martaguet B, Ainciburru PM, Codognet C, Sandler
B. 1978. Syndrome de West et vaccination anticoquelucheuse. [West's
syndrome and vaccination against whooping cough.] Bordeaux Medical
11:471-475.
Burnet M, White DO. 1972. Natural History of Infectious Disease,
4th edition. Cambridge: University Press.
Burnette WN. 1990. The advent of recombinant pertussis vaccines.
Bio/Technology 8:1002-1005.
Burnette WN, Cieplak W, Mar VL, Kaljot KT, Sato H, Keith JM.
1988a. Pertussis toxin S1 mutant with reduced enzyme activity and a
conserved protective epitope. Science 242:72-74.
Burnette WN, Mar VL, Cieplak W, Morris CF, Kaljot KT, Sato H,
Keith JM. 1988b. Toward development of a recombinant pertussis
vaccine. In: Technological Advances in Vaccine Development. New
York: Alan R. Liss, Inc.
Burnette WN, Mar VL, Cieplak W, Morris CF, Kaljot KT, Marchitto
KS, Sachdev RK, Locht C, Keith JM. 1988c. Direct expression of
Bordetella pertussis toxin subunits to high levels in
Escherichia coli. Bio/Technology 6:699-706.
Burnette WN, Bartley TD, Whiteley DW, Mar VL, Cieplak W, Keith
JM, Burns DL. 1989a. Recombinant analogs of pertussis toxin S1
subunit. In: Vaccines 89. Cold Spring Harbor, NY: Cold Spring
Harbor Laboratory.
Burnette WN, Whiteley DW, Mar VL, Burns DL, Kaslow HR, Cieplak
W, Keith JM, Bartley TD. 1989b. Developments toward a recombinant
pertussis vaccine. In: Atassi MZ, ed. Immunobiology of Proteins and
Peptides V. New York: Plenum Publishing Corp.
Burns DL, Hausman SZ, Witvliet MH, Brennan MJ, Poolman JT,
Manclark CR. 1988. Biochemical properties of pertussis toxin. Tokai
Journal of Experimental and Clinical Medicine
13(Suppl.):181-185.
Butler NR, Voyce MA, Burland WL, Hilton ML. 1969. Advantages of
aluminium hydroxide adsorbed combined diphtheria, tetanus and
pertussis vaccines for the immunisation of infants. British Medical
Journal 1:663-666.
Butler NR, Golding J, Haslum M, Stewart-Brown S. 1982. Recent
findings from the 1970 child health and education study:
preliminary communication. Journal of the Royal Society of Medicine
75:781-784.
Byers RK, Moll FC. 1948. Encephalopathies following prophylactic
pertussis vaccination. Pediatrics 1:437-457.
Byers RK, Rizzo ND. 1950. A follow-up study of pertussis in
infancy. New England Journal of Medicine 242:887-891.
Byrne EB, Ryan JM, Randolph MF, Horstmann DM. 1969. Live
attenuated rubella virus vaccines in young adult women. American
Journal of Diseases of Children 118:234-236.
Cadoz M, Arminjon F, Quentin-Miller MS, Armand J. 1986. Safety
and immunogenicity of Merieux acellular pertussis vaccines in adult
volunteers. In: Workshop on Acellular Pertussis Vaccines.
Transcript. Bethesda, MD: U.S. Department of Health and Human
Services.
Cameron J. 1976. Problems associated with the control testing of
pertussis vaccine. Advances in Applied Microbiology 20:57-80.
OCR for page 272
Page 272
Stewart GT. 1982. ABC of 1 to 7: whooping cough (letter).
British Medical Journal 284:1263.
Stewart GT. 1983a. Reactions to pertussis vaccine (letter).
Lancet 1:1217-1218.
Stewart GT. 1983b. Whooping cough and pertussis vaccine
(letter). British Medical Journal 287:287-289.
Stewart GT. 1985. Whooping cough and pertussis vaccine: a
comparison of risks and benefits in Britain during the period
1968-83. Developments in Biological Standardization 61:395-405.
Stewart GT. 1990. Safety of pertussis vaccine. Lancet
335:913-914.
Stewart GT, Wilson J. 1981. Pertussis vaccine and serious acute
neurological illness in children (letter). British Medical Journal
282:1968-1969.
Stewart-Harris C. 1981. Pertussis vaccine (letter). British
Medical Journal 283:494.
Stickl H, Schweier P, Van Thiel D. 1976. Preliminary results
with an oral application of killed pertussis bacteria in newborn
infants. Fourteenth Congress of the International Association of
Biological Standardization, 1975. Developments in Biological
Standardization 33:54-56.
Still GF. 1902. The Coulstonian lectures on some abnormal
physical conditions in children. Lancet 1:1008-1012, 1077-1082,
1163-1168.
Storsaeter J, Olin P, Renemar B, Lagergard T, Norberg R, Romanus
V, Tiru T. 1988. Mortality and morbidity from invasive bacterial
infections during a clinical trial of acellular pertussis vaccines
in Sweden. Pediatric Infectious Disease Journal 7:637-645.
Storsaeter J, Hallander HO, Farrington CP. 1990a. Evaluation of
laboratory methods used for the diagnosis of pertussis infection
and disease in the Vaccine Efficacy Trial in Sweden. In: Manclark
CR, ed. Sixth International Symposium on Pertussis, Abstracts. DHHS
Publication No. (FDA) 90-1162. Bethesda, MD: Public Health Service,
U.S. Department of Health and Human Services.
Storsaeter J, Hallander H, Farrington CP, Olin P, Mollby R,
Miller E. 1990b. Secondary analyses of the efficacy of two
acellular pertussis vaccines in a Swedish phase III trial. Vaccine
8:457-461.
Stott NCH, Davis RH. 1981. Pertussis vaccination and pseudo
whooping cough (letter). British Medical Journal 282:1870-1871.
Stout MG. 1988. U.S. clinical trials with Takeda acellular
pertussis vaccine. Tokai Journal of Experimental and Clinical
Medicine 13(Suppl.):21-28.
Strauss AA, Lehtinen LE. 1947. Psychopathology and Education in
the Brain-Injured Child. New York: Grune & Stratton.
Ström J. 1960. Is universal vaccination against pertussis
always justified? British Medical Journal 2:1184-1186.
Ström J. 1967a. Social development and declining incidence
of some common epidemic diseases in children: a study of the
incidence in different age groups in Stockholm. Acta Pediatrica
Scandinavica 56:159-163.
Ström J. 1967b. Further experience of reactions, especially
of a cerebral nature, in conjunction with triple vaccination: a
study based on vaccinations in Sweden, 1959-1965. British Medical
Journal 4:320-323.
Ström J. 1970. Reactions of a cerebral nature in
conjunction with triple vaccination in Sweden. International
Symposium on Pertussis, Bilthoven, 1969. Symposia Series in
Immunobiological Standardization 13:157-160.
OCR for page 273
Page 273
Stronk MG, Pittman M. 1955. The influence of pertussis vaccine
on histamine sensitivity of rabbits and guinea pigs and on the
blood sugar in rabbits and mice. Journal of Infectious Diseases
96:152-161.
Stuart-Harris CH. 1979. Experiences of pertussis in the United
Kingdom. In: Manclark CR, Hill JC, eds. International Symposium on
Pertussis. U.S. Department of Health, Education, and Welfare
Publication No. (NIH) 79-1830. Washington, DC: U.S. Government
Printing Office.
Stuart-Harris CH. 1981. Pertussis vaccine (letter). British
Medical Journal 283:494.
Stuart-Smith S. 1988. Judgment in Loveday vs. Renton &
Wellcome. Royal Courts of Justice, London, March 29-30, 1988.
Study of Neurologic Illness in Children. 1990. Case reports.
Unpublished.
Suffredini AF, Harpel PC, Parrillo JE. 1989a. Promotion and
subsequent inhibition of plasminogen activation after
administration of intravenous endotoxin to normal subjects. New
England Journal of Medicine 320:1165-1172.
Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley
RA, Parrillo JE. 1989b. The cardiovascular response of normal
humans to the administration of endotoxin. New England Journal of
Medicine 321:280-287.
Sugarman SD. 1990. The need to reform personal injury law
leaving scientific disputes to scientists. Science 248:823-827.
Sullivan CE. 1988. Upper airway function and sleep apnea:
relevance for unexpected death in infancy. In: Harper RM, Hoffman
HJ, eds. Sudden Infant Death Syndrome Risk Factors and Basic
Mechanisms. New York: PMA Publishing Corp.
Sutherland JA. 1953. Encephalopathy following
diphtheria-pertussis inoculation. Archives of Disease in Childhood
28:149-150.
Sutter RW, Cochi SL, Farizo KM, Zell ER. 1990. Pertussis
hospitalizations and mortality, United States, 1985-87: evaluation
of the completeness of national reporting. In: Manclark CR, ed.
Sixth International Symposium on Pertussis, Abstracts. DHHS
Publication No. (FDA) 90-1162. Bethesda, MD: Public Health Service,
U.S. Department of Health and Human Services.
Swartz TA, Klingberg W, Goldwasser RA, Klingberg MA, Goldblum N,
Hilleman MR. 1971. Clinical manifestations, according to age, among
females given HPV-77 duck rubella vaccine. American Journal of
Epidemiology 94:246-251.
Syukuda Y, Watanabe H, Suehara A, Fujii S, Kuno-Sakai H, Kimura
M. 1988. Aerosol infection test for evaluation of pertussis
vaccine. Tokai Journal of Experimental and Clinical Medicine
13(Suppl.):71-77.
Szabo-Adorjan E, Pozsgi N. 1969. Effect of anaphylactic shock
and pertussis vaccination on the oestrus cycle in rats and mice.
Archives Roumaines de Pathologie Experimentale et de Microbiologie
28:437-444.
Szatmari P, Tuff L, Finlayson AJ, Bartolucci G. 1990. Aspergers
syndrome and autism—neurocognitive aspects. Journal of the
American Academy of Child and Adolescent Psychiatry 29:130-136.
Szentivanyi A, Fishel CW, Talmage D. 1963. Adrenaline mediation
of histamine and serotonin hyperglycemia in normal mice and the
absence of adrenaline-induced hyperglycemia in pertussis sensitized
mice. Journal of Infectious Diseases 113:86-98.
Tabachnick II, Gulbenkian A. 1969. Adrenergic changes due to
pertussis: insulin, glucose and free fatty acids. European Journal
of Pharmacology 7:186-195.
OCR for page 274
Page 274
Tada T, Okumura K, Ochiai T, Iwasa S. 1972. Effect of
lymphocytosis-promoting factor of Bordetella pertussis on
the immune response. II. Adjuvant effect of the production of
reaginic antibody in the rat. International Archives of Allergy
43:207-216.
Taggart C. 1988. Judge must rule again on vaccine: company says
revealing recipe would be ruinous. Spokesman-Review, Spokane,
Washington, October 14, 1988.
Taranger J. 1982. Mild clinical course of pertussis in Sweden.
Lancet 2:1360.
Taranger J, Wiholm BE. 1987. Litet antal biverkningar
rapporterade efter vaccination mot massling-passjuka-roda hund.
Lakartidningen 84:948-950.
Tardieu M. 1988. Les complications neurologiques des
vaccinations. Gazette Medicale 95:27-30.
Taylor EM, Emery JL. 1982. Immunisation and cot deaths (letter).
Lancet 2:721.
Taylor FM. 1952. Myoclonic seizures in infancy and childhood.
Texas State Journal of Medicine 48:647-649.
Terlingen JBA, Peters PWJ, Walvoort HC. 1984. A biphasic serum
glucose response in mice to inoculation with pertussis vaccine.
Journal of Biological Standardization 12:151-157.
Thach BT. 1986. Sudden infant death syndrome: old causes
rediscovered? (letter). New England Journal of Medicine
315:126-128.
Thacker SB. 1988. Meta-analysis: a quantitative approach to
research integration. Journal of the American Medical Association
259:1685-1689.
Thier SO. 1968. Importance of the single case. New England
Journal of Medicine 278:1347.
Thoman ME. 1990. The clinical composite of severe pertussis
vaccine reactions following DPT vaccine inoculation(s). Institute
of Medicine Public Meeting on Adverse Consequences of Pertussis and
Rubella Vaccines, Washington, DC, January 10, 1990.
Unpublished.
Thompson GR, Ferreyra A, Brackett RG. 1971. Acute arthritis
complicating rubella vaccination. Arthritis and Rheumatism
14:19-26.
Thompson GR, Weiss JJ, Shillis JL, Brackett RG. 1973.
Intermittent arthritis following rubella vaccination: a three year
follow-up. American Journal of Diseases of Children
125:526-530.
Thompson J. 1985. Whooping cough: helping parents assess the
risks (editorial). Health Visitor 58:277.
Thorndike RL. 1963. The Concepts of Over- and Under-Achievement.
New York: Bureau of Publications, Teachers College, Columbia
University.
Tilelli JA, Manniello RL. 1990. Pertussis vaccine encephalopathy
(letter). Journal of the American Medical Association 264:2385.
Times (London). 1988. Evidence fails to prove vaccine causes
brain damage. March 31, 1988, Law Report, p. 18.
Tingle A. 1990. Evidence linking rubella vaccines to chronic
arthritis. Presentation for Committee to Review the Adverse
Consequences of Pertussis and Rubella Vaccines. Institute of
Medicine Workshop on Possible Adverse Consequences of Pertussis and
Rubella Vaccines, Washington, DC, May 14, 1990. Unpublished.
Tingle A. 1991. Personal communication to Institute of Medicine
Committee to Review the Adverse Consequences of Pertussis and
Rubella Vaccines.
Tingle AJ, Kettyls DM, Ford DK. 1978a. Arthritis following
rubella immunization:
OCR for page 275
Page 275
prospective serologic assessment. Annals of the Royal College of
Physicians and Surgeons of Canada 11:96.
Tingle AJ, Price GF, Ford DK. 1978b. Chronic recurrent joint
manifestations following rubella immunization: clinical and
immunologic studies in 6 adult females. Annals of the Royal College
of Physicians and Surgeons of Canada 11:96.
Tingle AJ, Ford DK, Price GE, Kettyls DWG. 1979a. Prolonged
arthritis in identical twins after rubella immunization (brief
report). Annals of Internal Medicine 90:203-204.
Tingle AJ, Kettyls GDM, Ford DK. 1979b. Studies on
vaccine-induced rubella arthritis: serologic findings before and
after immunization. Arthritis and Rheumatism 22:400-402.
Tingle AJ, Yang T, Allen M, Kettyls GD, Larke RP, Schulzer M.
1983. Prospective immunological assessment of arthritis induced by
rubella vaccine. Infection and Immunity 40:22-28.
Tingle AJ, Pot CH, Chantler JK. 1984. Prolonged arthritis,
viraemia, hypogammaglobulinaemia, and failed seroconversion
following rubella immunisation (letter). Lancet 1:1475-1476.
Tingle AJ, Chantler JK, Kettyls GD, Larke RPB, Schulzer M.
1985a. Failed rubella immunization in adults: association with
immunologic and virological abnormalities. Journal of Infectious
Diseases 151:330-336.
Tingle AJ, Chantler JK, Pot KH, Paty DW, Ford DK. 1985b.
Postpartum rubella immunization: association with development of
prolonged arthritis, neurological sequelae, and chronic rubella
viremia. Journal of Infectious Diseases 152:606-612.
Tingle AJ, Allen M, Petty RE, Kettyls GD, Chantler JK. 1986.
Rubella-associated arthritis. I. Comparative study of joint
manifestations associated with natural rubella infection and RA
27/3 rubella immunisation. Annals of the Rheumatic Diseases
45:110-114.
Tingle AJ, Pot KH, Yong FP, Puterman ML, Hancock EJ. 1989.
Kinetics of isotype-specific humoral immunity in rubella
vaccine-associated arthropathy. Clinical Immunology and
Immunopathology 53:S99-S106.
Tobin JOH. 1971. Rubella vaccination of postpartum women and of
adolescents in the northwest of England. Canadian Journal of Public
Health 62:64-67.
Tokai University, Department of Pediatrics. 1988. 5th
International Symposium on Pertussis. Abstracts. September 22-23,
1988, Copenhagen, Denmark.
Tondury G, Smith DW. 1965. Fetal rubella pathology. Journal of
Pediatrics 68:867-879.
Tonz O, Bajc S. 1980a. Zerebrale Krampfanfalle nach
Pertussis-Impfung. [Convulsions after whooping cough vaccination.]
Schweizerische Medizinische Wochenschrift 110:1965-1971.
Tonz O, Bajc S. 1980b. Krampfanfalle und Enzephalopathien nach
Pertussis-Impfung (Di-Te-Per). Helvetica Paediatrica Acta 35(Suppl.
45):20.
Toomey JA. 1949. Reactions to pertussis vaccine. Journal of the
American Medical Association 139:448-450.
Torch WC. 1982. Diphtheria-pertussis-tetanus (DPT) immunization:
a potential cause of the sudden infant death syndrome (SIDS)
(abstract). American Academy of Neurology, 34th Annual Meeting,
April 25-May 1. Neurology 32(4, part 2):A169-170.
OCR for page 276
Page 276
Torch WC. 1986. Characteristics of diphtheria-pertussis-tetanus
(DPT) postvaccinal deaths and DPT-caused sudden infant death
syndrome (SIDS): a review (abstract). Neurology 36(Suppl. 1):
148.
Townsend JJ, Baringer JR, Wolinsky JS, Malamud N, Mednick JP,
Panitch HS, Scott RA, Oshiro L, Cremer NE. 1975. Progressive
rubella panencephalitis: late onset after congenital rubella. New
England Journal of Medicine 292:990-993.
Toyota T, Kai Y, Kakizaki M, Sakai A, Goto Y, Yajima M, Ui M.
1980. Effects of islet-activating protein (IAP) on blood glucose
and plasma insulin in healthy volunteers (phase 1 studies). Tohoku
Journal of Experimental Medicine 130:105-116.
Trollfors B. 1984. Bordetella pertussis whole cell
vaccines: efficacy and toxicity. Acta Paediatrica Scandinavica
73:417-425.
Trollfors B, Rabo E. 1981. Whooping cough in adults. British
Medical Journal 283:696-697.
Tsairis P, Dick PJ, Mulder DW. 1972. Natural history of brachial
plexus neuropathy. Archives of Neurology 27:109-117.
Tsuboi T. 1977. Genetic aspects of febrile convulsions. Human
Genetics 38:169-173.
Tsuchiuia S, Kagawa K, Fukuyama Y. 1978. Critical evaluation of
the role of immunisation as an etiological factor in infantile
spasms (second report). Brain and Development 3:171.
Tuomanen E. 1986. Piracy of adhesins: attachment of
superinfection pathogens to respiratory cilia by secreted adhesins
of Bordetella pertussis. Infection and Immunity
54:905-908.
Tuomanen E, Weiss A. 1985. Characterization of two adhesins of
Bordetella pertussis for human ciliated
respiratory-epithelial cells. Journal of Infectious Diseases
152:118-125.
Tuomanen E, Weiss A, Rich R, Zak F, Zak O. 1985. Filamentous
hemagglutinin and pertussis toxin promote adherence of
Bordetella pertussis to cilia. Developments in Biological
Standardization 61:197-204.
Ueoka K. 1979. Clinical and electroencephalographic study in
febrile convulsions, with special reference to follow-up study.
Brain and Development 1:196.
Urisu A, Cowell JL, Manclark CR. 1986. Filamentous hemagglutinin
has a major role in mediating adherence of Bordetella
pertussis to human WiDr cells. Infection and Immunity
52:695-701.
U.S. Department of Health and Human Services. 1981. Estimated
Economic Costs of Selected Medical Events Known or Suspected to Be
Related to the Administration of Common Vaccines. NCHSR Research
Summary Series. DHHS Publication No. (PHS) 81-3272. Washington,
D.C.
U.S. Department of Health and Human Services. 1988. Status of
Acellular Pertussis Vaccines & Swedish Trial Update. Transcript
of a workshop held February 8-9, 1988, Bethesda, MD.
U.S. Office of Education. 1977. Assistance to states for
education for handicapped children: procedures for evaluating
specific learning disabilities. Federal Register
42:62082-62085.
U.S. Preventive Services Task Force. 1989. Guide to Clinical
Preventive Services. Washington, D.C.: U.S. Government Printing
Office.
OCR for page 277
Page 277
Valdes-Dapena M. 1990. Evidence linking pertussis vaccines to
sudden infant death syndrome (SIDS). Presentation for Committee to
Review the Adverse Consequences of Pertussis and Rubella Vaccines.
Institute of Medicine Workshop on Possible Adverse Consequences of
Pertussis and Rubella Vaccines, Washington, DC, May 14, 1990.
Unpublished.
Valensin PE, Rossolini GM, Cusi MG, Zanchi A, Cellesi C,
Rossolini A. 1987. Specific antibody patterns over a two-year
period after rubella immunization with RA 27/3 live attenuated
vaccine. Vaccine 5:289-294.
Valman HB. 1980. Contraindications to immunisation. British
Medical Journal 280: 1138-1139.
Valman HB. 1982. ABC of 1 to 7: whooping cough. British Medical
Journal 284:886-887.
Van den Berg BJ, Yerushalmy J. 1969. Studies on convulsive
disorders in young children. I. Incidence of febrile and nonfebrile
convulsions by age and other factors. Pediatric Research
3:298-304.
Van Heuven-Nolsen D, Schoute E, Verdouw PD, De Wildt DJ, Nijkamp
FP. 1989. In vivo beta2-adrenoceptor hyporesponsiveness in the
cardiovascular system of the pig after Bordetella pertussis.
European Journal of Pharmacology 162:135-141.
Veale H. 1866. History of an epidemic of rothein, with
observation on its pathology. Edinburgh Medical Journal
12:404-414.
Vellutino FR. 1978. Toward an understanding of dyslexia:
psychological factors in specific reading disability. In: Benton
AL, Pearl D, eds. Dyslexia: An Appraisal of Current Knowledge. New
York: Oxford University Press.
Vellutino FR. 1979. Dyslexia: Theory and Research. Cambridge:
MIT Press.
Venulet J, Ciucci A, Berneker GC. 1980. Standardized assessment
of drug-adverse reaction associations—rationale and
experience. International Journal of Clinical Pharmacology, Therapy
and Toxicology 18:381-388.
Venulet J, Berneker GC, Ciucci AG, eds. 1982. Assessing Causes
of Adverse Drug Reactions. New York: Academic Press.
Vergani D, Morgan-Capner P, Davies ET, Anderson AW, Tee DEH,
Pattison JR. 1980. Joint symptoms, immune complexes, and rubella
(letter). Lancet 2:321-322.
Vertes C, Gonczy S, Lendvay N, Debreczeni LA. 1987. A model for
experimental asthma: provocation in guinea-pigs immunized with
Bordetella pertussis. Bulletin of European Physiopathology and
Respiration 23(Suppl. 10): 11 s-113s.
Vesper J, Dietze RA. 1974. Zur Problematik der Verhutung,
Erfassung und Begutachtung von neurogenen Impfschaden im
Kindesalter aus klinischer und rechtlicher Sicht. Psychiatrie
Neurologie und Medizinische Psychologie 26:685-692.
Vesselinova-Jenkins CK. 1985. A live vaccine against pertussis.
Developments in Biological Standardization 61:517-524.
Villarejos VM, Arguedas JA, Hernandez GC, Buynak EB, Hilleman
MR. 1973. Clinical laboratory evaluation of rubella virus vaccine
given to postpartum women without pregnancy preventive. Obstetrics
and Gynecology 42:689-695.
Volkmar FR, Cohen DJ. 1986. Pervasive developmental disorders.
In: Cavenar JO, ed. Psychiatry, Vol. 2. Philadelphia: J.B.
Lippincott Co.
Volpe JJ, ed. 1987. Neurology of the Newborn, 2nd ed.
Philadelphia: W.B. Saunders.
OCR for page 278
Page 278
von Wehren U, von Torklus D. 1983. Arthritis nach
Roteln-Impfung. [Arthritis following rubella immunization].
Zeitschrift fuer Orthopaedie und Ihre Grenzgebeite 121:749-750.
Waight PA, Pollock TM, Miller E, Coleman EM. 1983. Pyrexia after
diphtheria/tetanus/pertussis and diphtheria/tetanus vaccines.
Archives of Disease in Childhood 58:921-923.
Walker A. 1990. Evidence linking pertussis vaccines to sudden
infant death syndrome (SIDS). Presentation for Committee to Review
the Adverse Consequences of Pertussis and Rubella Vaccines.
Institute of Medicine Workshop on Possible Adverse Consequences of
Pertussis and Rubella Vaccines, Washington, DC, May 14, 1990.
Unpublished.
Walker A, Rees L. 1985. Mythical contraindications to
vaccination (letter). Lancet 1:994.
Walker AM, Jick H, Perera DR, Thompson RJ, Knauss TA. 1987.
Diphtheria-tetanus-pertussis immunization and sudden infant death
syndrome. American Journal of Public Health 77:945-951.
Walker AM, Jick H, Perera DR, Knauss TA, Thompson RS. 1988a.
Neurologic events following diphtheria-tetanus-pertussis
immunization. Pediatrics 81:345-349.
Walker AM, Martin-Moreno JM, Artalejo FR. 1988b. Odd man out: a
graphical approach to meta-analysis. American Journal of Public
Health 78:961-966.
Wallace RB, Libert P, Ibrahim M, Isacson P. 1972. Joint symptoms
following an area-wide rubella immunization campaign: report of a
survey. American Journal of Public Health 62:658-661.
Wardlaw AC. 1988a. Laboratory aspects of the U.K. pertussis
vaccine test case. In: Mebel S, Stompe H, Drescher M, Rustenbach S.
FEMS-Symposium Pertussis, Proceedings of the Conference Organized
by the Society of Microbiology and Epidemiology of the German
Democratic Republic, Berlin, April 20-22, 1988.
Wardlaw AC. 1988b. Animal models for pertussis vaccine
neurotoxicity. Abstract from the 5th International Symposium on
Pertussis, Copenhagen, Denmark, September 22-23, 1988.
Wardlaw AC. 1988c. Animal models for pertussis vaccine
neurotoxicity. Tokai Journal of Experimental and Clinical Medicine
13(Suppl.):171-175.
Wardlaw AC, Parton R. 1983a. Pertussis vaccine. In: Easmon CSF,
Jeljaszewicz J, eds. Medical Microbiology, Vol. 2. New York:
Academic Press.
Wardlaw AC, Parton R. 1983b. Bordetella pertussis toxins.
Pharmacology of Therapeutics 19:1-53.
Wardlaw AC, Parton R, eds. 1988. Pathogenesis and Immunity in
Pertussis. New York: John Wiley & Sons.
Wardlaw AC, Boorman L, Reid R. 1971. Assay of endotoxin by the
hypothermic response of mice. British Journal of Experimental
Pathology 52:198-208.
Wassilak SGF, Smith GS, Garbe PL, Burstyn DG, Manclark CR. 1983.
Pertussis outbreak in a Colorado high school: use of a new ELISA
(abstract no. 725). In: Program and Abstracts of the 23rd
Interscience Conference on Antimicrobial Agents and Chemotherapy.
Washington, DC: American Society for Microbiology.
Wehrle PF. Injury associated with the use of vaccines. 1985.
Clinical Therapeutics 7:282-284.
OCR for page 279
Page 279
Weibel RE, Stokes J, Buynak EB, Hilleman MR. 1969. Live rubella
vaccines in adults and children. American Journal of Diseases of
Children 118:226-229.
Weibel RE, Stokes J, Buynak EB, Hilleman MR. 1972. Influence of
age on clinical response to HPV-77 duck rubella vaccine. Journal of
the American Medical Association 222:805-807.
Weibel RE, Stokes J, Buynak EB, Hilleman MR. 1969. Rubella
vaccination in adult females. New England Journal of Medicine
280:682-685.
Weibel RE, Villarejos VM, Klein EB, Buynak EB, McLean AA,
Hilleman MR. 1980. Clinical and laboratory studies of live
attenuated RA 27/3 and HPV 77-DE rubella virus vaccines.
Proceedings of the Society for Experimental Biology and Medicine
165:44-49.
Weigle K. 1989. Case definition: inclusion of cases with other
potential etiologies for case presentation. Institute of Medicine
Workshop on the National Childhood Encephalopathy Study,
Washington, DC, November 7-8, 1989. Unpublished.
Weihl C, Riley HD, Lapin JH. 1963. Extracted pertussis antigen:
a clinical appraisal. American Journal of Diseases of Children
106:210-215.
Weil ML, Itabashi HH, Cremer NE, Oshiro LS, Lennette EH, Carnay
L. 1975. Chronic progressive panencephalitis due to rubella virus
stimulating subacute sclerosing panencephalitis. New England
Journal of Medicine 292:994-998.
Weiss AA, Hewlett EL. 1986. Virulence factors of Bordetella
pertussis. Annual Reviews of Microbiology 40:661-686.
Weiss AA, Hewlett EL, Myers GA, Falkow S. 1983. Tn5-induced
mutations affecting virulence factors of Bordetella
pertussis. Infection and Immunity 42:33-41.
Weiss AA, Hewlett EL, Myers GA, Falkow S. 1984. Pertussis toxin
and extracytoplasmic adenylate cyclase as virulence factors in
Bordetella pertussis. Journal of Infectious Diseases
150:219-222.
Weiss NS. 1989. National Childhood Encephalopathy Study:
potential biases related to case and control selection. Institute
of Medicine Workshop on the National Childhood Encephalopathy
Study, Washington, DC, November 7-8, 1989. Unpublished.
Weller TH, Neva FA. 1962. Propagation in tissue culture of
cytopathic agents from patients with rubella-like illness.
Proceedings of the Society for Experimental Biology and Medicine
111:215-225.
Wentz KR. 1989. Case definition in the National Childhood
Encephalopathy Study: effect of inclusion of cases with other
potential causes for case presentation. Institute of Medicine
Workshop on the National Childhood Encephalopathy Study,
Washington, DC, November 7-8, 1989. Unpublished.
Wentz KR, Marcuse EK. 1991. Diphtheria-tetanus-pertussis vaccine
and serious neurologic illness: an updated review of the
epidemiologic evidence. Pediatrics 87:287-297.
Werne J, Garrow I. 1946. Fatal anaphylactic shock occurrence in
identical twins following second injection of diphtheria toxoid and
pertussis antigen. Journal of the American Medical Association
131:730-735.
Werner H, Strauss AA. 1941. Pathology of the figure-background
relation in the child. Journal of Abnormal Social Psychology
36:236-248.
Wetterlow LH, Edsall G. 1970. The effect of benzethonium
chloride on the antigens of pertussis vaccine. International
Archives of Allergy 37:143-153.
OCR for page 280
Page 280
White R, Finberg L, Tamer A. 1964. The modern morbidity of
pertussis in infants. Pediatrics 33:705-710.
Widelock D, Martorana NF, Schaeffer M. 1966. The effect of
pertussis vaccine on fetal wastage in mice. II. The sparing effect
of glucose. American Journal of Public Health 56:1588-1691.
Wiedmeier SE, Chung HT, Cho BH, Kim UH, Daynes RA. 1987. Murine
responses to immunization with pertussis toxin and bovine serum
albumin. I. Mortality observed after bovine albumin challenge is
due to an anaphylactic reaction. Pediatric Research 22:262-267.
Wiener SL, Tinker M, Bradford WL. 1959. Experimental
meningoencephalomyelitis produced by hemophilus pertussis. Archives
of Pathology 67:694-699.
Wiesenthal AM, Lauer BA. 1987. Syringe preparation technique and
minor adverse reactions to diphtheria-tetanus-pertussis
immunization. Pediatric Infectious Disease Journal 6:1048-1050.
Wiggins CA, Dykewicz MS, Patterson R. 1989. Idiopathic
anaphylaxis: a review. Annals of Allergy 62:1-4.
Wilkins J. 1986. Pertussis agglutinogen: an immunogen and an
allergen (letter). American Journal of Diseases of Children
140:507.
Wilkins J. 1988. What is "significant" and DTP reactions
(letter). Pediatrics 81:912.
Wilkins J, Williams FF, Wehrle PF, Portnoy B. 1971. Agglutinin
response to pertussis vaccine. I. Effect of dosage and interval.
Journal of Pediatrics 79:197-202.
Wilkins J, Chan S, Wehrle PF. 1987. Age and dose interval as
factors in agglutinin formation to pertussis vaccine. Vaccine
5:49-54.
Williams NM, Preblud SR. 1984. Rubella and congenital rubella
surveillance, 1983. Centers for Disease Control Surveillance
Summaries 33:1SS-10SS.
Williams RM. 1969. Reactions to triple vaccines in infancy. The
Medical Officer 122:274.
Williams WO. 1981. Whooping cough in adults. British Medical
Journal 283:1122.
Williams WO, Jones B. 1987. Study of intellectual performance of
children in ordinary schools after certain serious complications of
whooping cough. British Medical Journal 295:1044-1047.
Wing L. 1981. Sex ratios in early childhood autism and related
conditions. Psychiatry Research 5:129.
Wing L, Yeates SR, Brierley LM, Gould J. 1976. The prevalence of
early childhood autism: comparison of administrative and
epidemiological studies. Psychological Medicine 6:89-100.
Wirsing von König CH, Hoppe JE, Tacken A, Finger H. 1990.
Detection of Bordetella pertussis in clinical specimens. In:
Manclark CR, ed. Sixth International Symposium on Pertussis,
Abstracts. DHHS Publication No. (FDA) 90-1162. Bethesda, MD: Public
Health Service, U.S. Department of Health and Human Services.
Witney EW. 1940. Neuritis following rubella (letter). British
Medical Journal 1:831.
Witte JJ, Karchmer AW, Case G, Herrmann KL, Abrutyn E, Kassanoff
I, Neill JS. 1969. Epidemiology of rubella. American Journal of
Diseases of Children 118: 107-112.
Wolfe SM, ed. Questions and answers. Pertussis and pertussis
vaccine: the "P" in DPT. Public Citizen Health Research Group.
Health Letter 4:6-8.
OCR for page 281
Page 281
Wolff SM. 1973. Biological effects of bacterial endotoxins in
man. Journal of Infectious Diseases 128(Suppl.):S259-S264.
Woodbury LA. 1978. Incidence and prevalence of seizure disorders
including the epilepsies in the United States of America: a review
and analysis of the literature. In: Plan for Nationwide Action on
Epilepsy, Vol. 4: The Commission for the Control of Epilepsy and
its Consequences. DHEW Publication No. (NIH) 78-279. Washington,
D.C.: U.S. Department of Health, Educaion, and Welfare.
Yajima M, Hosoda K, Kanbayashi Y, Nakamura T, Nogimori K,
Muzushima Y, Nakase Y, Ui M. 1978. Islet-activating protein (IAP)
in Bordetella pertussis that potentiates insulin secretory
responses of rats. Journal of Biochemistry 83:295-303.
Yamauchi T. 1986. The controversy in clinical medicine regarding
the risks and benefits of pertussis immunization. Neurotoxicology
7:47-51.
Yamasaki S. 1983. Side effects after improved DPT vaccine.
Annales Paediatrici Japonici 29:24.
Yannet H, Deamer WC, Barba PS. 1949. Convulsive disorders in
children. Round Table Discussion, American Academy of Pediatrics.
Pediatrics 4:677-680.
Yannet H. 1951. The treatment and prognosis of convulsive
disorders in children. Bulletin of the New York Academy of Medicine
27:466-474.
Zahalsky AC. 1989a. Biological activities and properties of
Bordetella pertussis toxins. May 1989. Unpublished.
Zahalsky AC. 1989b. Some biochemical mechanisms and consequences
of the joint action(s) of pertussis toxin and endotoxin in humans.
June 1989. Unpublished.
Zahalsky AC. 1989c. Neurotoxicity via permeability of cerebral
capillaries. July 1989. Unpublished.
Zahalsky AC. 1989d. A contributing mechanism to cell injury
following inoculation with whole cell DTP vaccine (adsorbed):
ADP-ribosylation by pertussis toxin as potential inhibitor of
essential energy yielding reactions. October 1989. Unpublished.
Zahalsky AC. 1990. Scientific basis for including tests of acute
phase reaction products in clinical protocols designed to
investigate the cause of adverse reactions following inoculation(s)
in infants with DTP (ads.) vaccine. Institute of Medicine Public
Meeting on Adverse Consequences of Pertussis and Rubella Vaccines,
Washington, DC, January 10, 1990. Unpublished.
Zeffer KB, Sauer MV. 1988. Orchitis after a rubella vaccination:
a case report. Journal of Reproductive Medicine 33:80-81.
Zellweger H. 1959. Pertussis encephalopathy. Archives of
Pediatrics 76:381-386.
Zellweger H, Steinegger R. 1950. Zur Klinik und Pathogenese der
Pertussisencephalopathie. Helvetica Paediatrica Acta 5:139.
Zhang JM, Cowell JL, Steven AC, Carter PH, McGrath PP, Manclark
CR. 1985a. Purification and characterization of fimbriae from
Bordetella pertussis. Infection and Immunity 48:422-427.
Zhang JM, Cowell JL, Steven AC, Manclark CR. 1985b. Purification
of serotype 2 fimbrae of Bordetella pertussis and their
identification as a mouse protective antigen. Developments in
Biological Standardization 61:173-185.
Zuelzer WW, Mastrangelo R, Stulberg CS, Poulik MD, Page RH,
Thompson RI.
OCR for page 282
Page 282
1970. Autoimmune hemolytic anemia: natural history and
viral-immunologic interactions in childhood. American Journal of
Medicine 49:80-93.
Zupanska B, Lawkowicz W, Gorska B, Kozlowska J, Ochocka M,
Rokicka-Milewska R, Derulska D, Ciepielewska D. 1976. Autoimmune
haemolytic anaemia in children. British Journal of Haematology
34:511-520.
Representative terms from entire chapter:
american journal
